![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Aanjaneya Lifecare Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Quinine sulfate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2009-387 - Rev 00
This Chemical Type CEP, issued on April 06, 2011, remains in force until February 08, 2012, ensuring its reliability within the pharmaceutical industry.
Substance Number 19 associated with this CEP further emphasizes